Evidence-Based Medicine Guidelines
Haloperidol for agitation in dementia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Haloperidol for Agitation in Dementia." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/453967/all/Haloperidol_for_agitation_in_dementia.
Haloperidol for agitation in dementia. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/453967/all/Haloperidol_for_agitation_in_dementia. Accessed March 6, 2025.
Haloperidol for agitation in dementia. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/453967/all/Haloperidol_for_agitation_in_dementia
Haloperidol for Agitation in Dementia [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/453967/all/Haloperidol_for_agitation_in_dementia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Haloperidol for agitation in dementia
ID - 453967
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453967/all/Haloperidol_for_agitation_in_dementia
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
